The deadline has been extended for UAMS employees to submit innovative therapeutic or drug discovery ideas to the AR Health Ventures Accelerator (ARHVA) for significant
AR Health Ventures Accelerator proudly announces its inaugural cohort, funding innovative projects in biofilm inhibition, radiation-responsive cancer therapy, and advanced liver injury detection, marking a significant leap in medical research.
Learn about funding mechanisms and how to commercialize research and clinical innovations. Plus, be one of the first 50 to register and receive a free copy of ‘Research to Revenue: A Practical Guide to University Start-Ups’.
